Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

44 results about "Viral contamination" patented technology

Viral contamination is a potential safety threat common to all animal- and human-derived biologics produced in mammalian cell culture ( 4 ). A viral contamination can arise from a contaminated cell line source or from adventitious introduction of virus during production.

Sterilization and disinfection apparatus for medical hyperbaric oxygen chamber

PCT designated stageWO2025236413A1ChemicalsInfectious virusViral infection
The present invention relates to the technical field of disinfection for medical hyperbaric oxygen chambers. Disclosed is a sterilization and disinfection apparatus for a medical hyperbaric oxygen chamber. According to the present invention, a fixing plate is fixedly connected to a side of a fixing frame close to a fixing mechanism. A mounting plate is fixedly connected to a side of the fixing plate away from the fixing mechanism. Two sides of the mounting plate away from the fixing plate are fixedly connected to two ends of a disinfection lamp, respectively. A disinfection cylinder body is fixed to an air inlet end of an oxygen exhaust pipeline of the hyperbaric oxygen chamber. The disinfection lamp disinfects the gas flowing inside the pipeline, thereby effectively disinfecting and sterilizing the gas exhaled by patients in the hyperbaric oxygen chamber, which is then discharged into the atmosphere outside the chamber through the oxygen exhaust pipeline, avoiding the formation of a new virus source. The apparatus is designed to disinfect dedicated oxygen chambers for individuals infected with infectious viruses, avoiding the formation of a major viral contamination source, and preventing gas containing pathogens exhaled by patients from circulating inside the oxygen exhaust pipeline, thereby avoiding contamination of the pipelines inside the oxygen chamber.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY

Feline calicivirus VP1 recombinant protein and application thereof

PendingCN119552264AThe solution is not easy to obtainlow costSsRNA viruses positive-senseAntibody mimetics/scaffoldsFeline calicivirus infectionTGE VACCINE
The invention discloses a feline calicivirus VP1 recombinant protein and application thereof. The amino acid sequence of the feline calicivirus VP1 recombinant protein is shown as SEQ ID No.1 in a sequence table. The neutralizing titers of the feline calicivirus positive serum prepared by adopting the recombinant protein as an antigen and different gene groups are all up to 1: 4096 times or above, the requirements of ELISA and IFA tests can be met, the feline calicivirus positive serum obtained after immunization of the prepared recombinant protein is good in purity, free of bacteria, free of mycoplasma and exogenous virus pollution, high in specificity and good in clinical application prospect. And the strain can react with strains of different evolution groups well, and has good broad spectrum. Positive serum prepared from the recombinant protein prepared by the invention can be used for quality control of different gene group cat calicivirus vaccines, such as specificity test, exogenous virus test, diagnostic detection and the like.
Owner:CHINA ANIMAL HUSBANDRY IND

Epidemic prevention type building greening site for preventing viruses from polluting soil and underground water

The utility model discloses an epidemic prevention type building greening site capable of preventing viruses from polluting soil and underground water, belongs to the field of ecological buildings, and solves the problem that rainwater of an epidemic prevention type building carries viruses to cause environmental pollution. A plurality of water collecting tanks are arranged in a greening field around a building, the greening field sequentially comprises a plain soil layer, a first impermeable film, a first ceramsite layer, a first non-woven fabric, a first coarse sand layer, a first planting soil layer and a lawn from bottom to top, the first ceramsite layer is connected with the water collecting tanks through first seepage pipes, and the water collecting tanks are connected to a disinfection tank through drainage pipes. Rainwater in the epidemic prevention type building greening site is passively collected, treated and then discharged, and viruses are prevented from being diffused and spread along with the rainwater and soil.
Owner:中国市政工程西北设计研究院有限公司

QPCR (quantitative polymerase chain reaction) primer probe group for detecting various nodaviruses, detection method and application

The invention provides a qPCR (quantitative polymerase chain reaction) primer probe group for detecting various nodaviruses, a detection method and application, and belongs to the technical field of molecular biological detection. Aiming at various nodaviruses capable of infecting insect cell lines, including animal shed virus, Tn5 cell line virus, black beetle virus, borawa virus, nodavirus and macrobrachium rosenbergii nodavirus, a set of primer probe combination is designed. In the combination, part of viruses share the upstream primer and the probe, so that synchronous detection and identification of multiple target viruses in one reaction system are realized. The invention also provides a kit containing the primer probe group and a detection method. The detection method provided by the invention has the advantages of wide coverage range, high detection sensitivity, strong specificity, good matrix interference resistance and the like, and is suitable for safety detection and quality control of nodavirus pollution in insect cell banks, cell cultures and related biological products thereof.
Owner:SINO BIOLOGICAL INC

Sf9-pt cells free of rhabdovirus and their use

ActiveCN116515728BCell freeRhabdovirus carpio
This application provides a rhabdovirus-free Sf9-PT cell line and its applications. This cell line was deposited on March 15, 2023, at the China Center for Type Culture Collection (CCTCC), Wuhan University, Wuhan, China, with accession number CCTCC NO: C202334. The Sf9-PT cell line screened in this application is free from rhabdovirus contamination, allows for high-density culture, exhibits higher viral proliferation levels, and demonstrates more durable viral packaging stability. This cell line can serve as a modified alternative host for the development and commercial production of biological products and vaccines, and can more safely avoid the potential dangers posed by Sf-RV virus contamination.
Owner:PORTON BIOLOGICS LTD

Antiviral cells and uses thereof

ActiveCN111849921BHydrolasesGenetically modified cellsEngineered geneticViral contamination
The present invention provides a mammalian cell line that has been genetically engineered to make it resistant to viral entry and / or replication; and provides a method for using the cell line to reduce or prevent viral contamination of a bioproduction system.
Owner:EMD MILLIPORE CORP

Antimicrobial Barrier Device for Preventing Bacterial, Fungal and Viral Contamination of Purses, Shoulder Bags, Totes, Cases, Packs and Other Personal Luggage Devices

An antimicrobial barrier device is provided, adapted to shield a purse or other personal luggage device against microbial contamination and transfer. The anti-microbial barrier is designed to overlay and thereby anti-microbially shield a contact surface of the purse or luggage (typically a flat bottom or side thereof), effectively preventing viral, bacterial, fungal and protozoan contamination of the purse or luggage when the contact surface is rested upon a potentially contaminated surface, such as a floor, seat or countertop.
Owner:SKORA LISA

Fluorescence immunochromatography kit and detection reagent kit

The utility model relates to the technical field of kits, in particular to a fluorescence immunochromatography kit which comprises a kit body, a partition plate and a disinfection assembly, the bottom of the partition plate and the disinfection assembly are mutually fixed, the disinfection assembly comprises a miniature ultraviolet disinfection lamp, and the miniature ultraviolet disinfection lamp is installed at the bottom of the partition plate. The disinfection assembly further comprises a battery used for providing power for the miniature ultraviolet disinfection lamp, the battery is installed at the bottom of the partition plate, the disinfection assembly further comprises a controller used for controlling operation of the miniature ultraviolet disinfection lamp, and the controller is fixed to the bottom of the partition plate. The kit body is divided into a bottom cavity and an upper cavity through a partition plate, sample antigens are inactivated through ultraviolet rays emitted by the miniature ultraviolet disinfection lamp, and the surrounding environment can be prevented from being polluted by harmful bacteria or viruses.
Owner:ANHUI JIACHUANG BIOTECHNOLOGY CO LTD

Method for producing a composition having lipase activity and a composition suitable for pharmaceutical use with improved safety characteristics

The present invention relates to a method for producing a composition having lipase activity and a composition suitable for pharmaceutical use, which has improved safety characteristics. The present invention describes a method for producing a solid or semi-solid composition, particularly a solid oral composition for pharmaceutical use, the method comprising treating an enzyme or enzyme mixture having lipase activity and a surfactant component under defined process parameters. The method is suitable for reducing undesired biological contamination, such as viral contamination, of the enzyme or enzyme mixture while maintaining its desired biological activity, such as enzyme activity. The method is suitable for industrial use. Also described is a solid or semi-solid composition comprising an enzyme or enzyme mixture having lipase activity, a surfactant component and a polymer additive, optionally comprising other adjuvants. The composition can preferably be obtained by the method as described herein. The present invention also describes a pharmaceutical composition comprising the solid or semi-solid composition as described herein.
Owner:ABBOTT LAB GMBH +1

Typing detection system for sewage diarrhea virus

The present invention relates to the technical field of virus detection, and discloses a sewage diarrhea virus typing detection system, which comprises a pathogen enrichment unit, an improved polyethylene glycol precipitation method is adopted to carry out pathogen enrichment on a sewage sample; and the nucleic acid extraction unit is used for extracting nucleic acid in the enriched sample by using a magnetic bead extraction method. According to the typing detection system for the diarrhea viruses in the sewage, simultaneous detection and typing of various diarrhea viruses such as norovirus, rotavirus, adenovirus, astrovirus, parareovirus and fiveleaf virus in the sewage can be realized, the detection range is widened, powerful support is provided for comprehensive monitoring of virus pollution conditions in the sewage, and the system is suitable for popularization and application. According to the present invention, the multiple fluorescent RT-PCR technology is adopted, and the efficient sample enrichment and nucleic acid extraction method is combined, such that the detection sensitivity is improved, the low-concentration viral nucleic acid can be detected, and the potential viral threat is not missed;
Owner:青岛国际旅行卫生保健中心

A qPCR primer and probe set for detecting multiple nova viruses, detection method and application

This invention provides a primer-probe set, detection method, and application for qPCR detection of various nodaviruses, belonging to the field of molecular biology detection technology. This invention designs a primer-probe combination for various nodaviruses that can infect insect cell lines, including farm virus, Tn5 cell line virus, black beetle virus, Boralwa virus, Nodamura virus, and Macrobrachium rosenbergii nodavirus. In this combination, some viruses share upstream primers and probes, enabling simultaneous detection and identification of multiple target viruses in a single reaction system. This invention also provides a kit and detection method containing this primer-probe set. The detection method of this invention has advantages such as wide coverage, high detection sensitivity, strong specificity, and good resistance to matrix interference, and is suitable for the safety detection and quality control of nodavirus contamination in insect cell banks, cell cultures, and related biological products.
Owner:SINO BIOLOGICAL INC

Method and agent for inactivating bacteria or viruses, and antiviral substrate using said agent

[Problem] To provide an inexpensive means that can exert an inactivation effect on microorganisms without the presence of light while minimizing the burden on the environment. [Solution] A bacterium or a virus is inactivated by bringing a compound having a redox mechanism (in the formula, X-represents a counter anion, and the dashed line represents a bonding position with another atom) into contact with a subject at risk of contamination with the bacterium or the virus. # imgabs0 #
Owner:NISSAN MOTOR CO LTD +1

Preparation method of human serum albumin and purification method thereof

The present application provides a preparation method of human serum albumin, which comprises inoculating human serum albumin-producing Pichia pastoris into a culture medium for fermentation, and obtaining human serum albumin from the fermentation liquor; the culture medium is BSM culture medium with the concentration of all components reduced to at most 1 / 4 except for two components of glycerol and Pichia pastoris trace elements 1, preferably reduced to 1 / 4-1 / 2. The present application also provides a purification method of human serum albumin. The yield and the proportion of human serum albumin in total protein obtained by the preparation method of the present application are significantly higher than those of the prior art, the cost of the culture medium used in the preparation method is significantly reduced, and there is no risk of animal-derived virus contamination, thereby significantly reducing the cost of the preparation method. The recovery rate is significantly improved by using the purification method of the present application, and the purity of the final product is also significantly further improved.
Owner:SHANGHAI INST OF PHARMA IND CO LTD +1

Sheep embryo fibroblast line and application thereof

PendingCN121950687AAvoid the risk of contamination with other virusesquality improvementMicroorganism based processesSkeletal/connective tissue cellsCells isolationCapripoxvirus
The invention provides a sheep embryo fibroblast line and application thereof, and belongs to the technical field of cell biology. The name of the sheep embryo fibroblast line is sheep embryo fibroblast OEF, the sheep embryo fibroblast line is preserved in China Center for Type Culture Collection, the address is Wuhan University, Wuhan, China, the preservation date is January 26, 2022, and the preservation number is CCTCC NO: C202212. The sheep embryo fibroblast line can be used for separation and culture of bovine and sheep pox viridae viruses such as LSDV, GTPV, SPPV and ORFV, has the characteristics of short proliferation time and high virus titer, and can avoid the risk that other viruses are polluted by viruses generated by primary cell separation.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Systems and methods for identifying viral contaminants

The present disclosure is directed to a streamlined sample preparation process, VERA (Viral Enrichment by Reducing Artifacts), to tilt total genomic material in favor of DNA / RNA viral genomes. This reduction of host genomic artifacts can be completed in <8 hours from sample acquisition. Using a rapid library preparation protocol (˜1.5 minutes) and real-time nanopore sequencing, potential viral contamination, for example RNA viral contamination, can be identified in less than one workday from sample acquisition.
Owner:REGENERON PHARMACEUTICALS INC

Antiviral mobile respiratory personal protection device

Invention is described which sterilizes air contaminated with airborne virus by means of superheating the air to over 400 Fahrenheit then cooling air to breathable temperatures. The invention disposes a fan pushing contaminated air into a positive temperature coefficient semiconductor heater to superheat the air which is subsequently cooled by a two stage cooling system. First stage of the cooling system is an air-to-air heat exchanger using ambient air from second fan to cool the superheated air. The second stage of cooling is provided by a solid-state Peltier heat pump which further transfers heat energy to ambient air provided by a third fan. Invention is disposed onto a sealed helmet which the sterilized air is conveyed causing an overpressure to eliminate the possibility of contaminated air entering the helmet. The invention is entirely reusable after use in a contaminated environment and does not rely on filters to remove airborne virus.
Owner:DEWISPELAERE JEFFREY RICHARD

Acanthopanax compound polysaccharide empty capsule with immunocompetence and preparation method of acanthopanax compound polysaccharide empty capsule

The invention discloses an acanthopanax compound polysaccharide empty capsule with immunocompetence and a preparation method thereof, and relates to an acanthopanax compound polysaccharide capsule and a preparation method thereof. The acanthopanax compound polysaccharide empty capsule with immunocompetence is prepared from compound polysaccharide, a film-forming agent, a gelling agent, a coagulant aid and a plasticizer, the compound polysaccharide consists of acanthopanax polysaccharide and corn straw polysaccharide. According to the method, synergistic development of the acanthopanax residues and the corn straw is innovatively proposed, the extraction residues of the acanthopanax roots are converted into high-added-value raw materials, and the comprehensive utilization rate of medicinal materials is increased; by introducing agricultural waste straw polysaccharide, resource utilization of agricultural waste is achieved, and environmental pollution caused by straw burning is reduced. By adopting plant-derived substances, the possibility of animal-derived virus pollution is avoided, so that the problem of animal virus pollution risk is solved. The prepared acanthopanax compound polysaccharide hollow capsule is stable in mechanical property and relatively stable in chemical property, and the dissolution characteristic of the medicine is guaranteed.
Owner:HARBIN UNIV OF COMMERCE

Platelet-rich plasma vacuum blood collection tube containing biotin and recombinant humanized XVII type collagen as well as preparation method and application of platelet-rich plasma vacuum blood collection tube

The invention belongs to the technical field of medical cosmetology and tissue regeneration, and particularly relates to a platelet-rich plasma vacuum blood collection tube containing biotin and recombinant humanized XVII type collagen as well as a preparation method and application of the platelet-rich plasma vacuum blood collection tube. Separating the glue layer; an anticoagulant solution layer; the interior of the tube body is vacuumized, and the preset sequence of the functional solution layer, the separation gel layer and the anticoagulant solution layer is configured as follows: after blood is introduced and centrifuged, biotin and recombinant XVII type collagen can migrate from the bottom of the tube and are specifically compounded in a platelet rich plasma (PRP) layer above the separation gel layer; and forming a PRP composite liquid layer different from the red blood cell layer, the separation gel layer and the plasma layer. According to the invention, the time is saved, the pollution risk is reduced, the risks of immunological rejection and disease transmission are avoided, the immunogenicity and virus pollution risk are overcome, the stability and quality uniformity are ensured, and the method accords with the production specifications of medical apparatuses and instruments.
Owner:SHANGHAI KEHUADIAGNOSITIC MEDICAL PRODS

Systems and methods for identifying viral contaminants

The present disclosure is directed to a streamlined sample preparation process, VERA (Viral Enrichment by Reducing Artifacts), to tilt total genomic material in favor of DNA / RNA viral genomes. This reduction of host genomic artifacts can be completed in <8 hours from sample acquisition. Using a rapid library preparation protocol (˜15 minutes) and real-time nanopore sequencing, potential viral contamination, for example RNA viral contamination, can be identified in less than one workday from sample acquisition.
Owner:REGENERON PHARMACEUTICALS INC

Facility that uses tap water in building

To provide a facility using tap water in a building, with which it is possible to efficiently inhibit the proliferation of chlorine-resistant Methylobacteria or other bacteria or viruses or to efficiently sterilize or inactivate these bacteria or viruses that have proliferated.SOLUTION: A facility using tap water in a building, wherein the facility comprises a device that generates first modified water and second modified water, a pipe that supplies tap water to the device, a discharge unit for discharging the first modified water and the second modified water to a site at which contamination by microorganisms or viruses is to be suppressed, and a control unit, and wherein the facility discharges the first modified water and the second modified water while changing (a) the concentration of an active ingredient contained in each of the first modified water and the second modified water, and / or (b) the discharge time of the first modified water and the second modified water, in accordance with the discharge timing.SELECTED DRAWING: Figure 3
Owner:TOTO LTD

Stirring type bioreactor culture process of porcine circovirus type 2 recombinant baculovirus

PendingCN121294365AViruses/bacteriophagesAntigenPorcine Circoviruses
The invention provides a stirring type reactor culture process of a porcine circovirus type 2 recombinant baculovirus, which comprises the following steps: preparing a seed virus of the porcine circovirus type 2 recombinant baculovirus by using an insect cell Sf9 full-suspension culture process, and inoculating an insect cell High Five by using the seed virus prepared by using an Sf9 cell to perform antigen expression of the porcine circovirus type 2 recombinant baculovirus. A full-suspension culture mode is utilized, so that the labor intensity is reduced, the production cost is reduced, and pollution is not easily caused; 2) the risk of porcine virus pollution can be reduced by using insect cells and a baculovirus expression system; and 3) the characteristics (Sf9 and High Five) of different insect cells are simultaneously utilized to respectively carry out seed virus preparation and antigen expression, so that higher virus titer can be obtained, the virus titer is greater than or equal to 7.50 Log (TCID50 / mL), higher recombinant protein expression is obtained, and the protein expression quantity is greater than or equal to 150 mu g / mL.
Owner:TECON BIOPHARMACEUTICAL CO LTD

Methods of inactivating viral contaminants

The present invention relates to a method for preparing an antibody-containing solution free viral contaminants starting from cultured cells are described. The method include a step of subjecting the antibody containing solution to a mix of solvent and detergent or to high pH.
Owner:IGI THERAPEUTICS SA

A liquid formulation of a sustained-release conjugate of glucagon, GLP-1, and GIP triple-active compound.

To develop a stable liquid formulation of a persistent conjugate of a peptide active against all developed glucagon receptors, GLP-1 receptors, and GIP receptors, which can be stored for extended periods without concerns about viral contamination. [Solution] The present invention relates to a liquid formulation of a sustained-release conjugate of glucagon, GLP-1, and GIP triple-active compound, and a method for producing the same.
Owner:HANMI PHARM CO LTD

A nucleotide sequence for inducing RNA interference and reducing and eliminating viral contamination in cells and its application

The present invention discloses a dsRNA sequence and combination that can be used to reduce and eliminate Sf-Rhabdovirus contamination in Sf cells, as well as corresponding siRNA sequences, and DNA sequences and combinations corresponding to the dsRNA and combination, as well as the corresponding siRNA sequences. The present invention also discloses a method for reducing and eliminating Sf-Rhabdovirus in Sf cells using the above-mentioned nucleic acid sequence, and an Sf-Rhabdovirus-free cell line obtained thereby.
Owner:BEIJING SOLOBIO GENETECHNOLOGY CO LTD

Chicken embryo fibroblast cell, its preparation method and application

PendingCN122303136ABiotechnologyMuscle tissue
This invention discloses a chicken embryo fibroblast, its preparation method, and its application, relating to the field of biopharmaceutical technology. The preparation method of the chicken embryo fibroblast includes the following steps: S1, providing chicken embryos and obtaining the muscle tissue of the chicken embryos; S2, mixing the muscle tissue with a plant-derived compound digestion solution, and sequentially performing digestion, purification, and primary culture treatment using a serum-free special culture medium to obtain primary chicken embryo fibroblasts; wherein, the plant-derived compound digestion solution includes bromelain and papain. This invention, using a plant-derived compound digestion solution and a serum-free special culture medium, significantly improves the batch-to-batch stability, cell yield, and cell purity of the cells, reducing the risk of exogenous viral contamination. Therefore, the prepared chicken embryo fibroblasts exhibit high batch-to-batch stability and good reproducibility in viral culture.
Owner:SINOPHARM YANGZHOU VAC BIOLOGICAL ENG CO LTD +2

Primer and probe composition, detection method, kit and application thereof for simultaneously detecting mouse parvovirus and mouse thymic virus

ActiveCN116287447BMouse Thymic VirusMinute virus of mice
This invention belongs to the field of virus detection technology, specifically providing a primer and probe composition for the simultaneous detection of mouse parvovirus (MVM) and mouse thymvirus (MTLV), including primers and probes for detecting MVM and MTLV respectively. This invention also provides a kit comprising the above-mentioned primer and probe composition, and a method for the simultaneous detection of MVM and MTLV. The primer and probe composition, kit, and method provided by this invention can specifically amplify both MVM and MTLV viruses without cross-reacting with other viral nucleic acids or with the genomes of various commonly used cell lines that may be present in the sample. It exhibits good specificity, high sensitivity, and good reproducibility, overcoming the shortcoming of existing technologies that require separate detection of MVM and MTLV, and providing an excellent detection method for the prevention and control of exogenous viral contamination in rodent biological products.
Owner:CANVEST WUHAN BIOTECH

A group of shark nanoantibodies targeting shrimp infectious hypodermal and hematopoietic necrosis viruses and preparation methods thereof

The present invention discloses a group of shark nano antibodies targeting penaeid shrimp infectious subcutaneous and hematopoietic necrosis virus and a preparation method thereof. The amino acid sequence of the nano antibody is selected from any one of SEQ ID NO.8~14 amino acid sequences, which can be used for the detection of cp, nsp1, and nsp2 antigen proteins of infectious subcutaneous and hematopoietic necrosis virus. The preparation or screening method of the nano antibody comprises the following steps: A: expression and purification of cp, nsp1, and nsp2 antigen proteins; B: construction of shark natural library and / or shark immune library; C: auxiliary phage rescue and purification to obtain phage library; D: panning of anti-cp, anti-nsp1, and anti-nsp2 antigen protein phage library; E: phage-ELISA identification and sequencing, sequence alignment of cp, nsp1, and nsp2 nano antibodies with different CDR3 region sequences. The nano antibody provided by the present invention can specifically identify infectious subcutaneous and hematopoietic necrosis virus, can detect whether aquaculture animals, aquaculture water bodies, and aquaculture feed are contaminated by viruses, etc., and realize rapid detection.
Owner:SANYA INST OF OCEANOGRAPHY OCEAN UNIV OF CHINA

NK cell serum-free culture solution and NK cell culture method

InactiveCN121555422ACulture processBlood/immune system cellsProtein SensitizationMesoporous silica
The invention discloses an NK cell serum-free culture solution and a culture method of NK cells. The NK cell serum-free culture solution comprises a basic matrix, a multi-factor slow-release carrier and a function regulation component, the basic matrix comprises recombinant human serum albumin, recombinant human transferrin, plant-derived lipidosome, 12 core recombinant proteins and 5 micromolecular nutrient substances, and the plant-derived lipidosome is composed of soybean phospholipid and linolenic acid; the multi-factor slow-release carrier is amination modified mesoporous silicon nanoparticles, the amination modified mesoporous silicon nanoparticles load four types of functional factors, the culture solution adopts recombinant human-derived components and plant-derived lipidosome to construct a basic matrix, animal serum dependence is thoroughly abandoned, and the culture solution is a novel culture solution. The serum batch difference, virus pollution and heterogeneous protein sensitization risks are effectively avoided, meanwhile, the concentration of each component is accurate and controllable, and the batch-to-batch consistency and quality stability of the culture solution are remarkably improved.
Owner:XIAMEN SERBANGKE BIOTECHNOLOGY CO LTD